发布时间:2019-08-03 23:01 原文链接: NitrogendepedentregulationofRtg1andRtg3inTORpathway

Many key signaling molecules are conserved from yeast to man. mTOR is a protein kinase involved in nutrient and growth factor signaling in humans that has a yeast homolog with a similar role, TOR1. Like its human counterpart, yeast TOR1 is also inhibited by rapamycin. Signaling downstream of the TOR kinase pathways regulates the nuclear localization of several transcription factors in response to the carbon and nitrogen sources in the nutritional environment. Yeast cells activate the transcription factor GLN3 through the TOR pathway to control the use of nitrogen in response to nitrogen sensing. TOR phosphorylation of GLN3 when nitrogen is abundant causes cytoplasmic localization and inactivation of this transcription factor. When nitrogen is abundant, URE2 also interacts with GLN3 to keep it out of the nucleus and repressed. TOR also regulates GLN3 through regulation of the phosphatase SIT4 that dephosphorylates GLN3 inducing nuclear localization. The preferred nitrogen sources for yeast cells are glutamine and glutamate, which are derived from TCA cycle intermediates. The use of urea or ammonia as a nitrogen source is associated with induction of genes involved in the TCA cycle by the transcription factors RTG1 and RTG3. When glutamine is present, it causes repression of RTG1 and RTG3 by TOR1. The set of genes regulated downstream of TOR affect cell growth associated processes such as translation and nutrient use. The ability of TOR to selectively regulate different sets of genes in response to either carbon or nitrogen sources indicates that TOR can interact independently with these downstream effectors.

Contributor:

REFERENCES: Beck, T. and Hall, M.N. The TOR signalling pathway controls nuclear localization of nutrient-regulated transcription factors. Nature, vol 402(6762), 1999, 689-92. Bertram PG, et al. Convergence of TOR-nitrogen and Snf1-glucose signaling pathways onto Gln3. Mol. Cell. Biol., vol 22(4), 2002, 1246-52. Cardenas ME, et al. The TOR signaling cascade regulates gene expression in response to nutrients. Genes Dev., vol 13(24), 1999, 3271-79. Chan TF, Carvalho J, Riles L, and Zheng XF. A chemical genomics approach toward understanding the global functions of the target of rapamycin protein (TOR). PNAS, vol 97(24), November 2000, 13227-32. Komeili A, Wedaman K, O'Shea E, and Powers T. Mechanism of metabolic control: Target of rapamycin signaling links nitrogen quality to the activity of the Rtg1 and Rtg3 transcription factors. J. Cell Biol., vol 151(4), November 2000, 863-78. Kulkarni AA, et al. Gln3p nuclear localization and interaction with Ure2p in Saccharomyces cerevisiae. J. Biol. Chem., vol 276(34), 2002, 32136-44. Raught B, Gingras A, and Sonenburg N. The target of rapamycin (TOR) proteins. PNAS, vol 98(13), June 2001, 7037-44. Shamji AF, Kuruvilla FG, and Schreiber SL. Partitioning the transcriptional program induced by rapamycin among the effectors of the Tor proteins. Current Biology, vol 10(24), 2000, 1574-81.



相关文章

“3CoinONE全新体验气袋进样器”ANTOP奖进入专家评审阶段

万物蓬勃的7月里迎来了2022年ANTOP奖的申报和评审工作。由岛津企业管理(中国)有限公司申报的“3CoinONE全新体验气袋进样器”ANTOP奖进入专家评审阶段。奖项名称:3CoinONE全新体验......

青源峰达太赫兹在国际顶级期刊《TrendsinBiotechnology》发文

青岛青源峰达太赫兹科技有限公司研发团队在国际顶级期刊《TrendsinBiotechnology》(译名:《生物技术趋势》)在线发表题为“THzmedicalimaging:frominvitroto......

科学家将人工智能技术成功用于蛋白质复合物结构预测

蛋白质作为构成人体组织器官的支架和主要物质,在人体生命活动中起着重要作用。蛋白质的相互作用能产生许多效应,如形成特异底物作用通道、生成新的结合位点、失活、作用底物专一性和动力学变化等,细胞的代谢、信号......

发力癌症分子病理诊断,无锡臻和全资收购TissueofOrigin®

2021年9月9日,无锡臻和生物科技有限公司(以下简称“臻和科技”)与美国VyantBio公司签署TissueofOrigin®(以下简称“TOO®”)全球权益和ZL转让协议,全资收购这款唯一获FDA......

这3个杂志撤回中国学者249篇文章,包含上交、中山等名校

2021年7月20日,JournalofCellularPhysiology及JournalofCellularBiochemistry同时撤回了中国学者49篇文章。从2019年开始,Journalo......

firstinclass胃癌一线疗法获FDA突破性疗法

安进宣布,美国FDA授予其在研firstinclass单抗bemarituzumab突破性疗法认定,与改良FOLFOX6化疗方案(亚叶酸钙、氟尿嘧啶和奥沙利铂)联用,一线治疗FGFR2b过表达和HER......

金属所三维伊辛模型精确解研究取得进展

2007年,中国科学院金属研究所研究员张志东在英国《哲学杂志》(PhilosophicalMagazine)上发表论文,提出两个猜想,并在猜想基础上推定出三维伊辛模型的精确解。被《哲学杂志》审稿人评价......

肿瘤治疗的强心剂,中国学者开发肿瘤治疗新策略

磷酸甘油酸突变酶1(PGAM1)通过其代谢活性以及与其他蛋白质(例如α平滑肌肌动蛋白(ACTA2))的相互作用,在癌症代谢和肿瘤进展中起关键作用。变构调节被认为是发现针对PGAM1的高选择性和有效抑制......

肿瘤治疗的强心剂,中国学者开发肿瘤治疗新策略

磷酸甘油酸突变酶1(PGAM1)通过其代谢活性以及与其他蛋白质(例如α平滑肌肌动蛋白(ACTA2))的相互作用,在癌症代谢和肿瘤进展中起关键作用。变构调节被认为是发现针对PGAM1的高选择性和有效抑制......

llumina宣布推出新型基因分型芯片|支持AllofUs研究计划

2018年12月6日,来自圣迭戈的消息——Illumina公司(纳斯达克股票代码:ILMN)今天宣布推出新型高密度基因分型芯片Infinium™GlobalDiversityArray。这款芯片设计源......